OrbiMed’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.3M | Sell |
607,316
-72,500
| -11% | -$3.85M | 0.81% | 31 |
|
|
2025
Q1 | $29.4M | Hold |
679,816
| – | – | 0.7% | 39 |
|
|
2024
Q4 | $38.2M | Hold |
679,816
| – | – | 0.79% | 36 |
|
|
2024
Q3 | $46.3M | Buy |
679,816
+7,400
| +1% | +$504K | 0.84% | 36 |
|
|
2024
Q2 | $28.4M | Buy |
672,416
+532,016
| +379% | +$22.5M | 0.56% | 49 |
|
|
2024
Q1 | $9.7M | Buy |
+140,400
| New | +$9.7M | 0.18% | 82 |
|
|
2017
Q2 | – | Sell |
-602,900
| Closed | -$14.2M | – | 140 |
|
|
2017
Q1 | $14.2M | Sell |
602,900
-347,100
| -37% | -$8.2M | 0.16% | 86 |
|
|
2016
Q4 | $12.7M | Sell |
950,000
-151,600
| -14% | -$2.03M | 0.16% | 79 |
|
|
2016
Q3 | $20.5M | Sell |
1,101,600
-1,029,600
| -48% | -$19.1M | 0.23% | 71 |
|
|
2016
Q2 | $26.1M | Buy |
2,131,200
+240,800
| +13% | +$2.95M | 0.27% | 65 |
|
|
2016
Q1 | $12.7M | Buy |
+1,890,400
| New | +$12.7M | 0.13% | 78 |
|
|
2015
Q4 | – | Sell |
-1,778,000
| Closed | -$32M | – | 130 |
|
|
2015
Q3 | $32M | Hold |
1,778,000
| – | – | 0.32% | 58 |
|
|
2015
Q2 | $52.9M | Hold |
1,778,000
| – | – | 0.44% | 52 |
|
|
2015
Q1 | $39.2M | Hold |
1,778,000
| – | – | 0.33% | 58 |
|
|
2014
Q4 | $48.8M | Buy |
1,778,000
+55,000
| +3% | +$1.51M | 0.47% | 50 |
|
|
2014
Q3 | $33.4M | Hold |
1,723,000
| – | – | 0.35% | 52 |
|
|
2014
Q2 | $29.3M | Sell |
1,723,000
-170,000
| -9% | -$2.9M | 0.34% | 51 |
|
|
2014
Q1 | $26.8M | Sell |
1,893,000
-3,096,300
| -62% | -$43.9M | 0.33% | 52 |
|
|
2013
Q4 | $58.6M | Buy |
4,989,300
+309,000
| +7% | +$3.63M | 0.86% | 35 |
|
|
2013
Q3 | $55.2M | Sell |
4,680,300
-21,600
| -0.5% | -$255K | 0.99% | 32 |
|
|
2013
Q2 | $65.4M | Buy |
+4,701,900
| New | +$65.4M | 1.39% | 27 |
|